Diabetes Care:肌肉心肺耐力可测胰岛素抵抗

2013-04-16 晓东 编译 医学论坛网

    《糖尿病护理》(Diabetes Care)杂志2013年4月11日在线发表的一项研究指出,对于青年人群胰岛素抵抗与β细胞功能受损的一级预防,肌肉耐力与心肺耐力(CRF)水平或可作为靶向观测指标。   研究者在317例来自欧洲青年心脏研究(European Youth Heart Study)的受试者中,分别评估其腹、背部等长肌肉力量以

青年肌肉胰岛素抵抗
 

  《糖尿病护理》(Diabetes Care)杂志2013年4月11日在线发表的一项研究指出,对于青年人群胰岛素抵抗与β细胞功能受损的一级预防,肌肉耐力与心肺耐力(CRF)水平或可作为靶向观测指标。

  研究者在317例来自欧洲青年心脏研究(European Youth Heart Study)的受试者中,分别评估其腹、背部等长肌肉力量以及CRF与葡萄糖代谢的各自独立相关性,以及肌肉耐力+ CRF与葡萄糖代谢的联合相关性。

  研究者以应变测力计检测受试者等长背部舒张与腹部前屈时的最大自主收缩,以蹬车运动试验极限值评估CRF水平,以青少年至成年早期随访记录的空腹血浆胰岛素水平与空腹血糖水平预估胰岛素抵抗与β细胞功能。

  结果显示,等长肌力每1个标准差(0.16N/kg)的改变,空腹胰岛素水平、HOMA-IR(胰岛素稳态评估模型)、HOMA-B(β细胞功能稳态评估模型)在青少年人群中的改变分别达到−11.3%、−12.2%和−8.9%(经CRF与个体化生活方式、统计学因素校正)。CRF结果与之类似,经全身或腹部肥胖校正后相关程度亦无改变。肌肉耐力+ CRF与空腹胰岛素水平、HOMA-IR、HOMA-B的联合相关性两者叠加。男女两性等长肌肉力量、CRF水平最高三分位者血糖水平最低。 

胰岛素抵抗相关的拓展阅读:


Independent and Combined Association of Muscle Strength and Cardiorespiratory Fitness in Youth With Insulin Resistance and β-Cell Function in Young Adulthood
OBJECTIVE
To examine the independent and combined association of isometric muscle strength of the abdomen and back and cardiorespiratory fitness (CRF) in youth with indices of glucose metabolism in young adulthood among boys and girls from the European Youth Heart Study.
RESEARCH DESIGN AND METHODS
We used data from a population-based prospective cohort study among youth followed-up for up to 12 years (n = 317). In youth, maximal voluntary contractions during isometric back extension and abdominal flexion were determined using a strain-gauge dynamometer and CRF was obtained from a maximal cycle ergometer test. Insulin resistance (homeostasis model assessment of insulin resistance [HOMA-IR]) and β-cell function (homeostasis model assessment of β-cell function [HOMA-B]) were estimated from fasting serum insulin and glucose that were obtained in youth and at follow-up in young adulthood.
RESULTS
For each 1-SD difference in isometric muscle strength (0.16 N/kg) in youth, fasting insulin, HOMA-IR, and HOMA-B in young adulthood changed with −11.3% (95% CI, −17.0 to −5.2), −12.2% (−18.2 to −5.7), and −8.9% (−14.4 to −3.0), respectively, in young adulthood after adjustment for CRF and personal lifestyle and demographic factors. Results for CRF were very similar in magnitude, and the magnitude of associations for both exposures was unchanged with additional adjustment for general or abdominal adiposity in youth. Combined associations of muscle strength and CRF with fasting insulin, HOMA-IR, and HOMA-B were additive, and adolescents in the highest sex-specific tertile for both isometric muscle strength and CRF had the lowest levels of these glucose metabolism outcomes.
CONCLUSIONS
Increasing muscle strength and CRF should be targets in youth primordial prevention strategies of insulin resistance and β-cell dysfunction.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1901068, encodeId=71e5190106898, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jun 10 14:02:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636645, encodeId=898416366459c, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 29 07:02:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749397, encodeId=85971e49397cd, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jun 19 12:02:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684372, encodeId=966116843e21f, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Wed May 08 23:02:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759261, encodeId=3c6f1e59261aa, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Sep 21 03:02:00 CST 2013, time=2013-09-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1901068, encodeId=71e5190106898, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jun 10 14:02:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636645, encodeId=898416366459c, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 29 07:02:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749397, encodeId=85971e49397cd, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jun 19 12:02:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684372, encodeId=966116843e21f, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Wed May 08 23:02:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759261, encodeId=3c6f1e59261aa, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Sep 21 03:02:00 CST 2013, time=2013-09-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1901068, encodeId=71e5190106898, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jun 10 14:02:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636645, encodeId=898416366459c, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 29 07:02:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749397, encodeId=85971e49397cd, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jun 19 12:02:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684372, encodeId=966116843e21f, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Wed May 08 23:02:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759261, encodeId=3c6f1e59261aa, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Sep 21 03:02:00 CST 2013, time=2013-09-21, status=1, ipAttribution=)]
    2013-06-19 baoya
  4. [GetPortalCommentsPageByObjectIdResponse(id=1901068, encodeId=71e5190106898, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jun 10 14:02:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636645, encodeId=898416366459c, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 29 07:02:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749397, encodeId=85971e49397cd, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jun 19 12:02:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684372, encodeId=966116843e21f, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Wed May 08 23:02:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759261, encodeId=3c6f1e59261aa, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Sep 21 03:02:00 CST 2013, time=2013-09-21, status=1, ipAttribution=)]
    2013-05-08 aids222
  5. [GetPortalCommentsPageByObjectIdResponse(id=1901068, encodeId=71e5190106898, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Jun 10 14:02:00 CST 2013, time=2013-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636645, encodeId=898416366459c, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Mar 29 07:02:00 CST 2014, time=2014-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749397, encodeId=85971e49397cd, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Wed Jun 19 12:02:00 CST 2013, time=2013-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1684372, encodeId=966116843e21f, content=<a href='/topic/show?id=dfae5133e1d' target=_blank style='color:#2F92EE;'>#心肺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51337, encryptionId=dfae5133e1d, topicName=心肺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e128082444, createdName=aids222, createdTime=Wed May 08 23:02:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759261, encodeId=3c6f1e59261aa, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Sep 21 03:02:00 CST 2013, time=2013-09-21, status=1, ipAttribution=)]

相关资讯

Circulation:1型糖尿病强化降糖体重增加过多升高并发症危险

  近期两项前瞻性研究表明,体重增加过多(DCCT研究中)与持续增长的中心性肥胖、胰岛素抵抗、血脂异常、高血压,以及随访后期(EDIC研究中)更广泛的动脉粥样硬化相关。研究于2012年12月3日在线发表于《循环》(Circulation)杂志。   1型糖尿病(T1DM)的强化降糖治疗可减少糖尿病并发症,但可伴有体重增加过多、中心性肥胖和血脂异常。该前瞻性研究目的在于确定1型糖尿病患者糖尿病治疗

Diabetes Care:支链和芳香化氨基酸预测年轻人胰岛素抵抗

  芬兰一项研究表明,支链和芳香化氨基酸是年轻、血糖正常成人发生胰岛素抵抗的标志物,男性中的相关性更为显著,这提示了支链和芳香化氨基酸与未来糖尿病危险的关系至少部分是通过胰岛素抵抗介导的。该研究11月5日在线发表于《糖尿病护理》(Diabetes Care)杂志。   支链和芳香化氨基酸与2型糖尿病危险相关,但其潜在的机制尚不清楚。研究者从青年芬兰心血管危险研究人群中分析了1680名受

LRP16基因对胰岛素分泌和胰岛素抵抗的影响

  本课题通过研究LRP16基因在MIN6(小鼠胰岛素瘤细胞)中的功能以及在3T3-L1(脂肪细胞)、C2-C12(肌肉细胞)、HepG2(肝细胞)中对胰岛素抵抗的影响发现,LRP16在MIN6中具有多种作用,如可通过调节胰岛素基因及其转录因子来调节胰岛素含量;调控细胞增殖和凋亡;调节胰岛素分泌。同时,LRP16在脂肪细胞、肌肉细胞和肝细胞中也发挥着重要作用,LRP16过表达可上调多种炎性因子(T

ISME J:阴沟肠杆菌可能是肥胖的关键原因

  “人要是发胖,哪怕喝凉水都会长肉。”不少减肥的人士会有这种感慨。究竟什么导致肥胖?近来上海交大教授发表的一篇学术成果显示,一种叫做阴沟肠杆菌的肠道细菌是造成肥胖的直接元凶之一。这也是国际上首次证明肠道细菌与肥胖之间具有直接因果关系。   这一成果是上海交大赵立平教授领导的实验室实验证明的,并发表在12月13日出版的国际微生物生态学领域的顶级学术期刊ISME Journal上。

PLoS Genet:面对2型糖尿病,胖瘦是否有区别?

体型肥胖者罹患2型糖尿病通常可以从胰岛素抵抗角度解释,然而为什么体型瘦弱的人同样会得糖尿病?2012年5月的PLoS Genet杂志上刊出了一篇论文就探寻了瘦人和胖人在2型糖尿病发病上的差异(PLoS Genet. 2012 May;8(5):e1002741)。 该研究旨在通过对2型糖尿病病例按BMI分层,来确认LAMA1基因的遗传风险变异,并发现瘦人体内更多的风险变异。毫无疑问,弄清楚瘦

Diabetes:早产者较足月产者胰岛素敏感性稍低

  一项研究表明,早产出生的成年人在中年时出现胰岛素抵抗,但这种现象与其子女的胰岛素抵抗不相关。   为了评价早产出生的成年人及其子女的胰岛素敏感性和分泌功能。新西兰奥克兰大学霍夫曼教授选取早产和足月产的成年人,以及他们足月产的子女(5-10岁)作为试验对象进行了一项研究。评价胰岛素敏感性和分泌功能,在成年组中采用高血糖钳夹试验,在儿童组中采用最小量的伯格曼静脉葡萄糖耐量试验。该研究结果发表在《